Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 12 studies | 27% ± 7% | |
| mesothelial cell | 3 studies | 20% ± 3% | |
| epithelial cell | 3 studies | 33% ± 17% | |
| retinal pigment epithelial cell | 3 studies | 25% ± 7% | |
| GABAergic neuron | 3 studies | 21% ± 2% | |
| glutamatergic neuron | 3 studies | 20% ± 4% | |
| myoepithelial cell | 3 studies | 30% ± 9% |
Insufficient scRNA-seq data for expression of CDH3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| uterus | 98% | 2749.15 | 166 / 170 | 89% | 173.24 | 407 / 459 |
| ovary | 100% | 6357.37 | 180 / 180 | 69% | 40.55 | 297 / 430 |
| prostate | 97% | 2780.65 | 237 / 245 | 62% | 22.00 | 312 / 502 |
| lung | 55% | 368.50 | 317 / 578 | 81% | 100.30 | 930 / 1155 |
| skin | 73% | 2195.67 | 1314 / 1809 | 59% | 66.12 | 278 / 472 |
| esophagus | 40% | 2174.00 | 585 / 1445 | 88% | 132.11 | 161 / 183 |
| thymus | 36% | 186.63 | 235 / 653 | 86% | 76.24 | 521 / 605 |
| breast | 61% | 1803.62 | 279 / 459 | 59% | 42.72 | 656 / 1118 |
| bladder | 33% | 420.76 | 7 / 21 | 77% | 87.11 | 386 / 504 |
| ureter | 0% | 0 | 0 / 0 | 100% | 43.45 | 1 / 1 |
| spleen | 100% | 1743.24 | 240 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 172.18 | 44 / 45 |
| kidney | 93% | 1208.90 | 83 / 89 | 3% | 2.10 | 31 / 901 |
| intestine | 6% | 27.00 | 57 / 966 | 85% | 49.82 | 449 / 527 |
| pancreas | 6% | 25.51 | 21 / 328 | 83% | 63.90 | 147 / 178 |
| stomach | 16% | 76.24 | 56 / 359 | 67% | 36.45 | 191 / 286 |
| brain | 45% | 181.76 | 1199 / 2642 | 1% | 0.53 | 7 / 705 |
| adipose | 31% | 337.66 | 371 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 5% | 1.11 | 4 / 80 |
| heart | 3% | 15.76 | 26 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 2% | 9.50 | 23 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 8.34 | 4 / 258 | 0% | 0 | 0 / 230 |
| liver | 0% | 1.45 | 1 / 226 | 1% | 0.59 | 4 / 406 |
| peripheral blood | 0% | 3.72 | 4 / 929 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.44 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007601 | Biological process | visual perception |
| GO_0007043 | Biological process | cell-cell junction assembly |
| GO_0001895 | Biological process | retina homeostasis |
| GO_0034332 | Biological process | adherens junction organization |
| GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0007275 | Biological process | multicellular organism development |
| GO_0031424 | Biological process | keratinization |
| GO_0007155 | Biological process | cell adhesion |
| GO_0010838 | Biological process | positive regulation of keratinocyte proliferation |
| GO_0044331 | Biological process | cell-cell adhesion mediated by cadherin |
| GO_0032773 | Biological process | positive regulation of tyrosinase activity |
| GO_0022405 | Biological process | hair cycle process |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0043568 | Biological process | positive regulation of insulin-like growth factor receptor signaling pathway |
| GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO_0048023 | Biological process | positive regulation of melanin biosynthetic process |
| GO_0051796 | Biological process | negative regulation of timing of catagen |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0009410 | Biological process | response to xenobiotic stimulus |
| GO_1902910 | Biological process | positive regulation of melanosome transport |
| GO_0016477 | Biological process | cell migration |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016342 | Cellular component | catenin complex |
| GO_0005912 | Cellular component | adherens junction |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030054 | Cellular component | cell junction |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0008013 | Molecular function | beta-catenin binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | CDH3 |
| Protein name | Cadherin 3 Cadherin-3 (Placental cadherin) (P-cadherin) |
| Synonyms | CDHP |
| Description | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. |
| Accessions | J3QR60 ENST00000566808.2 ENST00000567674.1 J3QKW6 ENST00000569080.2 J3QL41 ENST00000264012.9 [P22223-1] ENST00000429102.6 [P22223-2] J3QL75 ENST00000542274.5 J3QR34 ENST00000569036.2 J3KRQ1 ENST00000568292.1 P22223 |
